Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome.
Gilboa-Geffen, Adi
Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome. [electronic resource] - PloS one 2011 - e28727 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0028727 doi
Animals
Biomarkers--metabolism
Cell Line
Disease Models, Animal
Humans
Inflammation Mediators--metabolism
Leukocytes, Mononuclear--pathology
Mice
NF-kappa B--metabolism
Saliva--metabolism
Salivary Glands--metabolism
Signal Transduction
Sjogren's Syndrome--metabolism
Toll-Like Receptor 9--agonists
Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome. [electronic resource] - PloS one 2011 - e28727 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0028727 doi
Animals
Biomarkers--metabolism
Cell Line
Disease Models, Animal
Humans
Inflammation Mediators--metabolism
Leukocytes, Mononuclear--pathology
Mice
NF-kappa B--metabolism
Saliva--metabolism
Salivary Glands--metabolism
Signal Transduction
Sjogren's Syndrome--metabolism
Toll-Like Receptor 9--agonists